| [1] |
DU Jinghui, HE Xin, LIU Jing, LIU Ruiyan, BAO Zhijun, WANG Jun, ZHAO Yan, LEI Yaorong, LIU Min, LIU Xu.
Evaluation of 7 oscillating mixing methods for SARS-CoV-2 nucleic acid determination
[J]. Laboratory Medicine, 2023, 38(7): 680-685.
|
| [2] |
ZHANG Yaxu, CUI Yanwei, LIU Ziyan.
Preliminary research for the determination of HPV E6/E7 mRNA by nucleic acid molecular hybridization-flow cytometry
[J]. Laboratory Medicine, 2023, 38(1): 46-50.
|
| [3] |
ZHANG Xiaoying.
Relationship between the changes of TK1 and ID-1 levels and curative effect in cervical cancer patients before and after neoadjuvant chemotherapy
[J]. Laboratory Medicine, 2020, 35(2): 108-111.
|
| [4] |
SHEN Qionghua.
Role of HPV DNA typing in the differential diagnosis of cervical lesions and cervical cancer
[J]. Laboratory Medicine, 2019, 34(6): 498-501.
|
| [5] |
CAI Pengfei, XU Zehui, WANG Jingren, YAN Tizhen.
Results' analysis of human papillomavirus determination of 9 810 patients in Liuzhou,Guangxi
[J]. Laboratory Medicine, 2019, 34(3): 246-248.
|
| [6] |
YANG Yang, CHEN Liangyuan, CAO Pengju, CHEN Shaoting, ZHANG Qiuqin, HUANG Chunli, WU Qiumei, CHEN Falin.
Analysis of HPV infection and gene subtypes in physical examination women in Fuzhou
[J]. Laboratory Medicine, 2019, 34(2): 144-147.
|
| [7] |
SUN Yongmei, CHEN Zhaowu, ZHANG Yang, WAN Lingling, LI Ming, DENG Fang.
HPV infection status of cervical cancer patients in Anhui and role of HPV determination in monitoring the curative effect of radiotherapy
[J]. Laboratory Medicine, 2019, 34(10): 897-900.
|
| [8] |
XUAN Qiankun, GUO Jian, WU Wenjuan, LI Guangbo.
Clinical application of human papillomavirus E6/E7 mRNA determination
[J]. Laboratory Medicine, 2018, 33(7): 640-643.
|
| [9] |
HUANG Qunhuan, HONG Ling, TAO Chunlin, HUANG Xuhong.
Regulator T cells and cytokines in peripheral blood of cervical cancer patients with different stages
[J]. Laboratory Medicine, 2017, 32(9): 769-772.
|
| [10] |
CHEN Dan, XU Ting, ZHANG Jiexin, ZHAO Hong, RONG Guodong, PAN Shiyang, WANG Fang, HUANG Peijun.
Performance of real-time fluorescence PCR for the determination of CYP2C19 polymorphisms
[J]. Laboratory Medicine, 2017, 32(9): 801-805.
|
| [11] |
YAN Xiaohui, LIN Jinduan.
Relationship between human papillomavirus infection and the severity of cervical lesions
[J]. Laboratory Medicine, 2017, 32(8): 700-703.
|
| [12] |
ZHAO Peiyu, CHEN Aozheng, QIN Jinlong, SONG Liwen, CHENG Jiajing.
Cervista HR-HPV DNA testing combined with TCT in cervical cancer screening
[J]. Laboratory Medicine, 2017, 32(4): 322-325.
|
| [13] |
ZHANG Xuedan, WENG Yuesong.
HPV DNA typing combined with "three-ladder" screening program in the diagnosis of cervical precancerous lesions and prognosis
[J]. Laboratory Medicine, 2017, 32(11): 990-993.
|
| [14] |
DIAO Wenjing, SUN Hong, GUO Qisang, WANG Li, TAO Xiang, SUI Long.
The expression and its difference of cornulin in cervical lesions
[J]. Laboratory Medicine, 2015, 30(9): 898-902.
|
| [15] |
JIN Lilan, CAI Gang, LIN Lin, WANG Xianghui.
Taqman-MGB method for determining CYP3A5 rs776746 site SNP and the influence of this site on the metabolism of tacrolimus
[J]. Laboratory Medicine, 2015, 30(8): 830-834.
|
